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September 8, 2010 
Dear Professor Ahluwalia, 
 
 Please, find enclosed the revised version of our original report entitled 
"Effects of ß-adrenoceptor stimulation on delayed rectifier K+ currents in canine 
ventricular cardiomyocytes" (MS#: 2009BJP-1701-RP.R1). Your and the referees’ 
suggestions were strictly followed and new experiments were performed according to 
these comments. Changes made in the manuscript are indicated with red colour, 
detailed responses to the reviewers are enclosed below. We hope that the revised 
version of our manuscript will meet your and the referee’s satisfaction and the 
manuscript will be considered suitable for publication in British Journal of 
Pharmacology. 
  
Best regards, 
 
Peter P. Nanasi 
Professor of Physiology 
 
 
 
 
Response to the Editor 
 
We have made the following major changes in the manuscript in accordance with the 
comments of the Editor and Reviewer 2: 
 
1. The effect of ISO was tested in the presence of the selective beta-1 blocker 
CGP-20712A (300 nM), which has fully prevented the effect of ISO on IKr - 
similarly to results obtained with 100 nM metoprolol. This information has 
been included to the Results section and presented also in Fig. 2.C. 
2. All PKC data (including text and figures) have been removed from the revised 
manuscript. 
3. We followed the BJP’s nomenclature for drugs, receptors and ion channels 
(according to BJP’s Guide to Receptors and Channels). This statement, 
(referring to the relevant citation from Alexander et al.) has been appended to 
the end of the Methods section. According to this, “beta-adrenergic” was 
replaced with “beta-adrenoceptor” and “isoproterenol” with isoprenaline. 
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We thank the kind help of the Editor, since we believe that her/his suggestions 
resulted in a substantial improvement of the manuscript. 
 
 
 
Response to Reviewer 2 
 
1. The effect of ISO was tested in the presence of the selective beta-1 blocker 
CGP-20712A (300 nM), which has fully prevented the effect of ISO on IKr - 
similarly to results obtained with 100 nM metoprolol. This information has 
been included to the Results section and presented also in Fig. 2.C. 
2. Reviewer 2 has convinced us that there were uncertainties regarding the 
interpretation of our data with the PKC blockers chelerythrine and GF-
109203X. Indeed, - in absence of data obtained from expressed HERG 
channels - we cannot exclude direct effects of these agents on IKr. Therefore – 
in accordance with the Editor’s suggestion – all PKC data have been removed 
from the manuscript. 
3. We are indebted to Reviewer 2 for the idea that helped to explain the 
differences observed between the effects of ISO on IKr and IKs. We have 
accepted this argumentation and included it in the Discussion section. 
 
 
We thank the kind help of the Reviewer, since we believe that his/her suggestions 
resulted in a substantial improvement of the manuscript. 
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Summary  
Background and purpose. While the slow delayed rectifier K+ current (IKs) is known to 
be enhanced by stimulation of ß-adrenoceptors in several mammalian species, 
phosphorylation-dependent regulation of the rapid delayed rectifier K+ current (IKr) is 
controversial. 
Experimental approach. In the present study, therefore, the effect of isoprenaline (ISO), 
activators and inhibitors of the PKA pathway on IKr and IKs were studied in canine 
ventricular myocytes using the whole cell patch clamp technique. 
Key results. IKr was significantly increased (by 30-50 %) following superfusion with 
ISO, forskolin or intracellular application of PKA activator cAMP analogues (cAMP, 8-
Br-cAMP, 6-Bnz-cAMP). Inhibition of PKA by Rp-8-Br-cAMP had no effect on baseline 
IKr. The stimulating effect of ISO on IKr was completely inhibited by selective ß1-
adrenoceptor antagonists (metoprolol and CGP-20712A), by the PKA inhibitor Rp-8-Br-
cAMP, and by the PKA activator cAMP analogues, but not by the EPAC activator 8-
pCPT-2'-O-Me-cAMP. In comparison, IKs was increased threefold by activation of PKA 
(by ISO or 8-Br-cAMP), and strongly reduced by the PKA inhibitor Rp-8-Br-cAMP. The 
ISO-induced enhancement of IKs was decreased by Rp-8-Br-cAMP and completely 
inhibited by 8-Br-cAMP. 
Conclusions and implications. The results indicate that stimulation of ß1-adrenoceptors 
increases IKr, similar to IKs, via activation of PKA in canine ventricular cells. 
 
Keywords: ß-adrenoceptors, isoprenaline, cAMP, PKA, delayed rectifier K+ current, IKr, 
IKs, dog myocytes. 
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 3 
Abbreviations: IKr, rapid delayed rectifier K+ current; IKs, slow delayed rectifier K+ 
current; ISO, isoprenaline; PKA, protein kinse A; PKC, protein kinase C; EPAC, 
exchange protein directly activated by cAMP 
 
Introduction 
Delayed rectifier K+ currents play pivotal role in repolarization of the cardiac action 
potential. In the ventricular myocardium of most mammalian species, including dog and 
human, the delayed rectifier K+ current is composed of two independent components, a 
rapid delayed rectifier K+ current (IKr) and a slow delayed rectifier K+ current (IKs) 
(Gintant, 1996; Li et al., 1996). Both components are controlled by catecholamines, and 
are important targets for antiarrhythmic drug action. While IKs is known to be enhanced 
by stimulation of ß-adrenoceptors, phosphorylation-dependent regulation of IKr is 
controversial (Thomas et al., 2004). PKA-mediated phosphorylation of expressed HERG 
channels significantly decreased IKr tail currents (Thomas et al., 1999; Wei et al., 2002). 
Similarly, stimulation of ß-adrenoceptors by 10 µM isoprenaline (ISO) decreased IKr in 
voltage-clamped guinea-pig ventricular myocytes (Karle et al., 2002). In contrast to these 
results, Heath and Terrar (2000) found that IKr was enhanced by ISO in guinea-pig 
ventricular cells provided the conditions necessary to activate the PKC pathway were 
met, i.e. Ca2+ current was not blocked, cytosolic Ca2+ was not buffered, and the cell 
interior was not dialyzed. In the absence of relevant human data we decided to study the 
effects of ß-adrenoceptor stimulation on delayed rectifier K+ currents in ventricular 
cardiomyocytes of the dog, a species that has action potential characteristics and 
properties of the underlying transmembrane ion currents most resembling those in 
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 4 
humans (Szentandrássy et al., 2005; Szabó et al., 2005). It was found that ISO increased 
IKr significantly in canine ventricular myocytes by activation of PKA and this effect is 
mediated by stimulation of ß1-adrenoceptors. 
 
Methods 
Single canine ventricular myocytes were obtained from hearts of adult mongrel dogs 
using the segment perfusion technique (Magyar et al., 2000). The animals (10-20 kg) 
were anaesthetized with ketamine hydrochloride (Calypsol) 5 mg kg-1 i.v.plus xylazine 
(CP-Xylazine) 0.04 mg kg-1. After the chest had been opened the heart was rapidly 
removed and the left anterior descending coronary artery was perfused using a 
Langendorff apparatus. Ca2+-free JMM solution (Joklik modification of Eagle’s 
Minimum Essential Medium, Sigma), supplemented with taurine (2.5 g l-1), pyruvic acid 
(175 mg l-1), ribose (750 mg l-1), allopurinol (13.5 mg l-1) and NaH2PO4 (200 mg l-1), was 
used during the initial 5 min of perfusion to remove Ca2+ and blood from the tissue. After 
addition of NaHCO3 (1.3 g l-1) the pH of this perfusate was adjusted to 6.9 by 
equilibrating the solution with a mixture of 95% O2 and 5% CO2. Cell dispersion was 
performed for 30 min in the same solution containing, in addition,  collagenase (660 mg l-
1
, Worthington CLS-II), bovine serum albumin (2 g l-1) and CaCl2 (50 µM). During the 
isolation procedure the solutions were gassed with carbogen and the temperature was 
maintained at 37 oC. The cells were rod shaped and showed clear striation when the 
external calcium was restored. 
 IKr and IKs were recorded at 37oC from Ca2+-tolerant canine ventricular cells 
superfused with oxygenated Tyrode solution containing (in mM) NaCl 140, KCl 5.4, 
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 5 
CaCl2 2.5, MgCl2 1.2, HEPES 5, glucose 10, at pH 7.4. This superfusate was 
supplemented with 5 µM nifedipine plus 1 µM E-4031 when measuring IKs, or 5 µM 
nifedipine plus 1 µM HMR-1556 when recording IKr, in order to eliminate L-type Ca2+ 
currents, IKr, or IKs, respectively. Suction pipettes, fabricated from borosilicate glass, had 
tip resistances of 1.5-2 MΩ after being filled with pipette solution composed of (in mM) 
K-aspartate 100, KCl 45, MgCl2 1, HEPES 5, EGTA 10, K-ATP 3. The pH of this 
solution was adjusted to 7.2 with KOH. Membrane currents were recorded with an 
Axopatch-200B amplifier (Axon Instruments) using the whole cell configuration of the 
patch clamp technique. After a high (1-10 GΩ) resistance seal had been established by 
gentle suction, the cell membrane beneath the tip of the electrode was disrupted by 
further suction or by applying 1.5 V electrical pulses for 1 ms. Ion currents were 
normalized to cell capacitance, determined in each cell using short hyperpolarizing pulses 
from -10 mV to -20 mV. The series resistance was typically 4-8 MΩ before 
compensation (usually 50-80%) prior to the measurement. Experiments were discarded 
when the amplitude of IKr or IKs was unstable within the initial 5 min of the experiment, 
or the series resistance was high or increased during the measurement. Outputs from the 
clamp amplifier were digitized at 20 kHz using an A/D converter (Digidata-1200, Axon 
Instruments) under software control (pClamp 6.0, Axon Instruments). 
 All values presented are arithmetic means ± SEM. Statistical significance of 
differences was evaluated by using one-way ANOVA followed by Student's t test for 
paired or unpaired data, as appropriate. Differences were considered significant when the 
P value was less than 0.05.  
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 6 
The principles of laboratory animal care (NIH publication No. 85-23, revised 1985) and 
current version of the Hungarian Law on the Protection of Animals were strictly followed 
throughout the experiments. Drug and molecular target nomenclature conforms to Guide 
to Receptors and Channels (Alexander et al., 2009).  
 
Results 
Effect of ISO on IKr 
IKr was activated by 250 ms depolarizing pulses to +10 mV applied at a rate of 0.05 Hz. 
IKr was characterized as tail current amplitudes determined as the difference between the 
peak current and the pedestal value observed following repolarization to the holding 
potential of -40 mV in the presence of 5 µM nifedipine plus 1 µM HMR-1556. Exposure 
of myocytes to ISO for 3-4 min increased IKr tail amplitude in a readily reversible manner 
(Figure 1a-c). The effect of ISO developed rapidly, the maximal effect was typically 
achieved within 2-3 min. These current tails (including the baseline amplitude as well as 
the ISO-induced component) were fully eliminated by 1 µM E-4031 (the IKr tail 
amplitude decreased to 0.01±0.002 pA/pF in the presence of E-4031, n=5), therefore the 
current can be considered to be purely IKr mediated by HERG channels (Figure 1d). The 
ISO-induced enhancement of IKr was caused by a leftward shift in the voltage-
dependence of activation of IKr (the midpoint potential was shifted from +5.6±0.9 mV to -
4.6±1.2 mV), while no significant change was found in the slope factor (6.7±0.5 versus 
7.4±0.5 mV-1) in the 4 myocytes studied (Figure 1.e). 
The stimulating effect of ISO on IKr was concentration-dependent, 1 µM ISO 
increased IKr by 37±3 % (Figure 2a). By fitting these results to the Hill equation an EC50 
value of 13.6±2.5 µM and a Hill coefficient of close to unity were obtained. Since 100 
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 7 
nM ISO resulted in a nearly maximal activation of IKr, this concentration was used in the 
following experiments. The effect of ISO was fully prevented by pretreatment with either 
100 nM metoprolol or 300 nM CGP-20712A - both are known to be selective inhibitors 
of ß1-adrenoceptors at these concentrations (Figure 2b and c). 
The signal transduction pathway mediating the ISO-induced stimulation of IKr 
was investigated using specific PKA activators and inhibitors. The effect of ISO was 
mimicked (i.e. IKr was increased in a similar extent) by various types of PKA activators, 
including 3 µM forskolin, 250 µM intracellular cAMP or 8-Br-cAMP (Figure 3). Similar 
results were obtained with 100 µM 6-bnz-cAMP (selective PKA activator with no effect 
on EPAC), while the same concentration of 8-pCPT-2'-O-Me-cAMP, a cAMP analogue 
known to activate EPAC without altering the activity of PKA (Holz et al., 2008), failed to 
enhance IKr. Intracellular application of 100 µM Rp-8-Br-cAMP, a cAMP analogue that 
is a selective PKA inhibitor, had no effect on baseline IKr.  
The effect of ISO on IKr was fully prevented by pretreatment with some PKA 
activators (forskolin, 8-Br-cAMP, and 6-bnz-cAMP), and by the PKA inhibitor (Rp-8-Br-
cAMP). It was only partially eliminated in the presence of cAMP, while the EPAC 
activator 8-pCPT-2'-O-Me-cAMP had no effect (Figure 3). These results indicate that the 
ISO-induced enhancement of IKr is critically dependent on activation of PKA. 
 
Effect of ISO on IKs 
IKs was activated by 3 s long depolarizing pulses to +30 mV delivered at a rate of 0.1 Hz 
from the holding potential of -40 mV. Tail currents, obtained after repolarization in the 
presence of 5 µM nifedipine plus 1 µM E-4031, were used to characterize IKs. Exposure 
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 8 
of myocytes to 10 and 100 nM ISO increased IKs tail amplitude to 194±28 and 293±41 %, 
of the control, respectively, in a largely reversible manner (Figure 4). The current was 
fully eliminated by 1 µM HMR-1556, indicating that it was purely IKs. 
 Baseline IKs was significantly reduced by selective inhibition of PKA using 100 
µM intracellular Rp-8-Br-cAMP (1.63±0.22 pA/pF in control, n=13 versus 0.47±0.06 
pA/pF in the presence of Rp-8-Br-cAMP, n=5). On the other hand, full activation of PKA 
by loading the pipette with 250 µM of the non-hydrolyzable cAMP derivative 8-Br-
cAMP, increased IKs to 4.53±0.63 pA/pF (n=5), which was three times higher than its 
control value (Figure 5). The effect of ISO on IKs was reduced in the presence of Rp-8-
Br-cAMP, and ISO failed to enhance IKs any more when PKA was fully activated by 8-
Br-cAMP. 
 
Discussion and conclusions 
In the present study the effects of the ß-adrenoceptor agonist ISO on the two components 
of the delayed rectifier K+ current, IKr and IKs, were studied and compared in canine 
myocytes. This is the first time an enhancement of IKr by ISO has been demonstrated in 
canine ventricular cells, which may be an important mechanism of defense against 
lengthening of action potentials in the case of ß-adrenoceptor stimulation. This ISO-
induced enhancement of IKr seems to be mediated by activation of PKA, since the effect 
of ISO was eliminated after either inhibition or full activation of PKA. It must be noted, 
however, that cAMP – in contrast to 8-Br-cAMP and 6-bnz-cAMP – failed to fully 
prevent the action of ISO. This may be explained by the proper compartmentalization of 
the PKA-channel complex, suggesting that the submembrane phosphodiesterase barrier 
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 9 
may limit the accessibility of PKA from the intracellular side (Jurevicius and 
Fischmeister, 1996; Fischmeister et al., 2006). Thus cAMP – but not 8-Br-cAMP – might 
partially be degraded locally by phosphodiesterase. 
In strong support of the PKA-dependent enhancement of IKr is the finding that 
when the current was observed in the presence of cAMP analogues it was markedly 
elevated resulting in permanent activation of the enzyme. However, in contrast to our 
results, IKr was shown to be reduced following activation of PKA in oocytes expressing 
HERG channels (Thomas et al., 1999; Wei et al., 2002). The reason for this discrepancy 
is not clear; it may be due to the lack of other important members of the underlying signal 
transduction pathway in the oocytes, but it may reflect interspecies differences as well. 
Similar to our results, Heath and Terrar (2000) found that IKr was enhanced by 10 
µM ISO in guinea-pig ventricular cells if the conditions required to activate the 
conventional PKC isoenzymes were met, i.e. Ca2+ current was not blocked, cytosolic 
Ca2+ was not buffered, and the cell interior was not dialyzed. They concluded that this 
stimulating effect was mediated via activation of the PKC pathway, involving crosstalk 
between PKA and PKC. However, activation of the conventional PKC isoforms with 
thymelatoxin was shown to decrease IKr in oocytes (Thomas et al., 2003). Furthermore, 
our experimental conditions did not favour the activation of conventional PKC 
isoenzymes, since Ca2+ current was blocked by 5 µM nifedipine, the cytosolic Ca2+ was 
strongly buffered by 10 mM EGTA, and the cell interior was dialyzed. 
 Similar to IKr, IKs was also equally enhanced by exposure to ISO and intracellular 
application of 8-Br-cAMP; however, marked differences were observed between IKr and 
IKs in response to ISO after inhibition of PKA. Rp-8-Br-cAMP strongly compromised 
Formatted
Formatted
Formatted
Formatted
Formatted
Formatted
Formatted
Formatted
Formatted
Deleted: S
Deleted:  argument
Deleted: ing
Deleted: drastic elevation 
Deleted: of
Deleted: - 
Deleted:  -
Deleted: w
Deleted:  –
Deleted: probably 
Deleted: ly
Deleted: to be
Deleted:  
Deleted: ory
Deleted:  a
Deleted: ly
Deleted: ,
Page 11 of 24
British Pharmacological Society
British Journal of Pharmacology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 10 
baseline IKs, but failed to modify baseline IKr at all. This may indicate a more marked 
contribution of the cAMP/PKA pathway to the basal activity of IKs compared to that of 
IKr. On the other hand, pretreatment with Rp-8-Br-cAMP fully prevented the effect of 
ISO on IKr but only decreased it on IKs. Thus it appears that a moderate suppression of the 
cAMP/PKA pathway is sufficient to blunt the effect of ISO on IKr, which may be the 
consequence of a less effective stimulus transduction targeting the HERG channel. 
However, it is also possible that different PKA isoenzymes with different sensitivities to 
inhibitors are involved in mediating the effects of ß-adrenoceptor stimulation to IKr and 
IKs. Hence, further studies are required to elucidate the differences between the fine 
tuning of ß-adrenoceptor stimulation of IKr and IKs. 
 In summary, IKr, similar to IKs, is enhanced by ISO in canine ventricular myocytes 
via activation of the cAMP/PKA system. Due to the particular importance of ß-
adrenoceptor stimulation in controlling cardiac repolarization and the susceptibility to 
arrhythmias, the detailed mechanism of regulation may be a promising subject of further 
studies. 
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Figure legends 
 
Figure 1  Effects of isoprenaline (ISO) on IKr current. (a-c) IKr current traces showing tail 
currents as relaxation of current during repolarization to -40 mV under control conditions 
(a), following exposure to 100 nM ISO (b), and after washing the cells in ISO-free 
solution (c).  (d) Representative experiment demonstrating the effect of 100 nM ISO on 
IKr and the full suppression of the ISO-induced current by 1 µM E-4041.  (e)Voltage-
dependence of activation of IKr in control and in the presence of 100 nM ISO. Tail current 
amplitudes measured at each test potential was normalized to the respective tail current 
obtained at +20 mV. Symbols and bars are means ± SEM, n=4. 
 
Figure 2  (a) Cumulative concentration-dependent effect of isoprenaline (ISO) on IKr tail 
current amplitude studied in 8 myocytes. (b, c) Effects of 100 nM ISO in the presence of 
100 nM metoprolol (n=6) and 300 nM CGP-20712A (n=4). IKr amplitudes were 
normalized to their respective control values. Columns and bars indicate means ± SEM. 
*Denote significant (P<0.05) differences from control (100 %) determined using paired t-
test. 
 
Figure 3  Role of the cAMP/PKA pathway in regulation of IKr.  Lefthand column of each 
pair shows IKr tail current amplitudes measured in control (no drug, n=13), following 
superfusion with forskolin (3 µM, n=6), and after internal application of cAMP (250 µM, 
n=9), 8-Br-cAMP (250 µM, n=8), 6-bnz-cAMP (100 µM, n=8), 8-pCPT-2'-O-Me-cAMP 
(100 µM, n=6) and Rp-8-Br-cAMP (100 µM, n=6).  Righthand column of each pair 
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indicates IKr tails obtained following superfusion with 100 nM ISO. Data are means ± 
SEM. *Indicate significant (P<0.05) differences from the control (no drug) IKr amplitude, 
determined using unpaired t-test. +Denote ISO-induced differences from the respective 
pre-ISO values, determined using paired t-test. 
 
Figure 4  Effects of isoprenaline (ISO) on IKs current. (a-c) IKs tail current traces obtained 
at repolarization to -40 mV under control conditions (a), following exposure to 100 nM 
ISO (b), and after washing the cells in ISO-free solution (c).  (d)Representative 
experiment demonstrating the effect of 100 nM ISO on IKs and the full suppression of the 
ISO-induced current by 1 µM HMR-1556.  (e) Average data obtained in 11 myocytes 
showing the cumulative effect of 10 nM and 100 nM ISO on IKs tail current amplitude. 
Columns and bars are means ± SEM values. *Indicate significant (P<0.05) differences 
from control determined using paired t-test. 
 
Figure 5  Role of the cAMP/PKA pathway in regulation of IKs.  In (c), lefthand column 
of each pair shows IKs tail current amplitude measured in control (no drug, n=11), and 
after internal application of Rp-8-Br-cAMP (100 µM, n=5) and 8-Br-cAMP (250 µM, 
n=5).  Righthand column of each pair indicates IKs tails obtained following superfusion 
with 100 nM ISO. Data are means ± SEM. *Indicate significant (P<0.05) differences 
from the control (no drug) IKs amplitude determined using unpaired t-test. +Denote ISO-
induced differences from the respective pre-ISO values determined using paired t-test. 
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